(Sharecast News) - Shares in Moderna sparked on Wednesday, after the US drugs firm settled a long-running legal dispute concerning its Covid-19 vaccine.
Under the terms of the deal struck with Arbutus Biopharma and Genevant Sciences, Moderna will pay a $950m lump sum in the third quarter, with an additional $1.3bn...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE